Health CanadaGeneral Alert
ANZEMET (dolasetron mesylate) - Withdrawal of 20 mg/mL Intravenous Injection Due...
Published: April 28, 2011Recall ID: 25452Category: generalCountry: Canada
Product Description & Identification
ANZEMET (dolasetron mesylate) - Withdrawal of 20 mg/mL Intravenous Injection Due to Potential Risk of Arrhythmias - For Health Professionals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 25452 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/anzemet-dolasetron-mesylate-withdrawal-20-mgml-intravenous-injection-due-potential-0 |
| Title | ANZEMET (dolasetron mesylate) - Withdrawal of 20 mg/mL Intravenous Injection Due to Potential Risk of Arrhythmias - For Health Professionals |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2011-04-28 |
| Organization | Marketed health products |